Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Med Chem ; 1(6): 529-36, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16787337

ABSTRACT

NDP kinase catalyzes the last step in the phosphorylation of nucleotides. It is also involved in the activation by cellular kinases of nucleoside analogs used in antiviral therapies. Adenosine phosphonoacetic acid, a close analog of ADP already proposed as an inhibitor of ribonucleotide reductase, was found to be a poor substrate for human NDP kinase, as well as a weak inhibitor with an equilibrium dissociation constant of 0.6 mM to be compared to 0.025 mM for ADP. The X-ray structure of a complex of adenosine phosphonoacetic acid and the NDP kinase from Dictyostelium was determined to 2.0 A resolution showing that the analog adopts a binding mode similar to ADP, but that no magnesium ion is present at the active site. As ACP may also interfere with other cellular kinases, its potential as a drug targeting NDP kinase or ribonucleotide reductase is likely to be limited due to strong side effects. The design of new molecules with a narrower specificity and a stronger affinity will benefit from the detailed knowledge of the complex ACP-NDP kinase.


Subject(s)
Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Adenosine/analogs & derivatives , Adenosine/metabolism , Nucleoside-Diphosphate Kinase/chemistry , Phosphonoacetic Acid/analogs & derivatives , Adenosine/chemistry , Adenosine Diphosphate/chemistry , Adenosine Diphosphate/metabolism , Animals , Binding Sites , Catalysis , Crystallization , Dictyostelium/enzymology , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Humans , Kinetics , Models, Molecular , Molecular Structure , Nucleoside-Diphosphate Kinase/antagonists & inhibitors , Phosphonoacetic Acid/chemistry , Phosphonoacetic Acid/metabolism , Phosphonoacetic Acid/pharmacology , Structure-Activity Relationship , X-Ray Diffraction
2.
Biochim Biophys Acta ; 1526(2): 199-210, 2001 May 03.
Article in English | MEDLINE | ID: mdl-11325542

ABSTRACT

Copper complex formation equilibria of glycyl-L-histidyl-L-lysine (Gly-His-Lys, GHK) and of two synthetic analogues, where the histidine residue was replaced with a synthetic amino acid (L-spinacine or L-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid), have been carefully investigated using different experimental techniques: potentiometry, solution calorimetry, UV-VIS spectrophotometry, circular dichroism and electron paramagnetic resonance spectroscopies. All the ligands formed complexes having different stoichiometries and stabilities; evidence for the formation of binuclear species is also shown. The structures of the main complexes are discussed. It is suggested that the lateral lysine amino group participates in complex formation, but only at alkaline pH values: at physiological pH this group is protonated and available for possible interactions with cellular receptors. The above tripeptides have been tested for their enzymatic stability in human serum: the synthetic compounds showed no significant degradation for at least 3 h. Finally, their activity as growth factor has been studied in vitro. The two synthetic analogues showed an activity comparable to or even higher than that of GHK, thus suggesting their possible use as additives in cell culture media, even in the presence of serum. Relevant information on the GHK action mechanism as cell growth factor has been obtained: the formation of copper complexes, driven by the first (Gly) residue, appears necessary while the second residue (His) does not appear to play a specific role; the presence of the free side chain of the third residue (Lys) appears to be of fundamental importance.


Subject(s)
Copper/chemistry , Growth Substances/chemistry , Oligopeptides/chemistry , Peptides/chemical synthesis , Circular Dichroism , Copper/metabolism , Drug Design , Hydrogen-Ion Concentration , Oligopeptides/blood , Oligopeptides/metabolism , Peptide Hydrolases , Protons , Spectrophotometry , Temperature , Thermodynamics
3.
Biochem Biophys Res Commun ; 262(2): 401-5, 1999 Aug 27.
Article in English | MEDLINE | ID: mdl-10462487

ABSTRACT

The 3D structure of paramyxovirus hemagglutinin-neuraminidase has not yet been resolved; however, a theoretical model has been built by using influenza virus and bacterial neuraminidases as template [V. C. Epa (1997) Proteins Struct. Funct. Gen. 29, 264-281]. Two common features of the catalytic mechanism of the neuraminidases of known 3D structure are the anomeric specificity and the involvement of a tyrosine residue in the stabilization of the transition state. These key features have been investigated on the water-soluble ectodomain of the hemagglutinin-neuraminidase from Sendai virus (cHN). The anomeric specificity of the hydrolysis of the substrate by cHN has been investigated by NMR spectroscopy. The immediate product of the reaction was the alpha-anomer, meaning that cHN belongs between glycohydrolases retaining anomeric configuration like influenza virus neuraminidase. Measurements of the UV difference spectrum upon binding of the substrate analogue 2,3-dehydro 2-deossi N-acetyl neuraminic acid indicate the ionization of a tyrosine residue and decreased polarity in the environment of a tryptophan residue. Functional significance of the spectral data was derived from the known structure of influenza neuraminidase, where a tyrosinate ion is involved in the stabilization of the transition-state carbonium ion, and a tryptophan residue is involved in the binding of the acetyl moiety of the substrate. The data give experimental support to the 3D model of paramyxovirus neuraminidase.


Subject(s)
HN Protein/chemistry , Neuraminidase/chemistry , Respirovirus/enzymology , Catalytic Domain , HN Protein/metabolism , Hydrolysis , Isomerism , Models, Molecular , Neuraminic Acids/metabolism , Neuraminidase/metabolism , Nuclear Magnetic Resonance, Biomolecular , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...